PolyPid Strengthens Executive Team, Appointing Dr. Anthony Senagore as Senior Medical Director

PETAH TIKVA, Israel, July 12, 2021 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD ), a late-stage biopharma company focusing on developing targeted, locally administered and prolonged-release therapeutics to improve surgical outcomes, today announced that it has appointed leading colorectal surgeon